AC
AIMT
Aisling Capital’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $26M | Sell |
1,240,000
-750,000
| -38% | -$15.7M | 57.34% | 1 |
|
|
2019
Q2 | $41.4M | Hold |
1,990,000
| – | – | 68.67% | 1 |
|
|
2019
Q1 | $44.5M | Hold |
1,990,000
| – | – | 66.84% | 1 |
|
|
2018
Q4 | $47.6M | Hold |
1,990,000
| – | – | 13.48% | 2 |
|
|
2018
Q3 | $54.3M | Sell |
1,990,000
-250,000
| -11% | -$6.82M | 11.73% | 2 |
|
|
2018
Q2 | $60.2M | Hold |
2,240,000
| – | – | 7.91% | 2 |
|
|
2018
Q1 | $71.3M | Hold |
2,240,000
| – | – | 12.71% | 2 |
|
|
2017
Q4 | $84.7M | Sell |
2,240,000
-750,000
| -25% | -$28.4M | 16.74% | 2 |
|
|
2017
Q3 | $74.1M | Hold |
2,990,000
| – | – | 12.18% | 2 |
|
|
2017
Q2 | $61.5M | Hold |
2,990,000
| – | – | 10.53% | 2 |
|
|
2017
Q1 | $65M | Hold |
2,990,000
| – | – | 11.83% | 3 |
|
|
2016
Q4 | $61.1M | Hold |
2,990,000
| – | – | 14.22% | 3 |
|
|
2016
Q3 | $44.9M | Hold |
2,990,000
| – | – | 9.24% | 4 |
|
|
2016
Q2 | $32.4M | Hold |
2,990,000
| – | – | 7.64% | 3 |
|
|
2016
Q1 | $40.5M | Hold |
2,990,000
| – | – | 8.12% | 3 |
|
|
2015
Q4 | $55.2M | Buy |
2,990,000
+170,000
| +6% | +$3.14M | 9.51% | 4 |
|
|
2015
Q3 | $71.4M | Buy |
+2,820,000
| New | +$71.4M | 12.55% | 2 |
|